EFFECT OF DIFFERENT DONOR CELLS ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION AND SELECTION IN-VITRO

被引:67
作者
SPIRA, AI [1 ]
HO, DD [1 ]
机构
[1] NYU,SCH MED,AARON DIAMOND AIDS RES CTR,NEW YORK,NY 10016
关键词
D O I
10.1128/JVI.69.1.422-429.1995
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We sought to determine the effects of different host cells on human immunodeficiency virus type 1 (HIV-1) infection in vitro. First, 17 primary viruses of various phenotypes were examined for replicative capacity in peripheral blood mononuclear cells (PBMC) from 10 healthy donors. While the range of infection was variable over a 40-fold range, it was substantially less than that previously reported (L. hi. Williams and M. W. Cloyd, Virology 184:723-728, 1991). In particular, no donor cells demonstrated total resistance to HIV-1 infection. We next cocultured PBMC from an HIV-l-infected patient with stimulated PBMC from three healthy donors to determine the effect of host cells on selection for a particular HIV-1 quasispecies. By using DNA sequencing, it was found that the dominant quasispecies (AD30-15) after culture was nearly identical in the cells of different donors. Furthermore, after 6 months in vivo, the patient developed a dominant proviral population in PBMC that was most closely related to the quasispecies preferentially selected in vitro, although this quasispecies was only a minor fraction of the sequences present earlier in PBMC. In subsequent biological characterizations, it was found that AD30-15 grew much better in PBMC and macrophages than did other related quasispecies. Hence, we conclude that the primary mechanism of in vitro selection for a particular HIV-1 variant in this case is mediated by the phenotypic properties of the virus and is less dependent on host cell origin. The findings reported here have important practical implications for studies of HIV-1 replication in primary cells derived from healthy donors.
引用
收藏
页码:422 / 429
页数:8
相关论文
共 38 条
[1]   CELLULAR PROTEINS BOUND TO IMMUNODEFICIENCY VIRUSES - IMPLICATIONS FOR PATHOGENESIS AND VACCINES [J].
ARTHUR, LO ;
BESS, JW ;
SOWDER, RC ;
BENVENISTE, RE ;
MANN, DL ;
CHERMANN, JC ;
HENDERSON, LE .
SCIENCE, 1992, 258 (5090) :1935-1938
[2]  
BUCHBINDER S, 1993, 9TH INT C AIDS, V1, P46
[3]  
CAO Y, UNPUB VIROLOGICAL IM
[4]   DEVELOPMENT OF A QUASI-SPECIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INVIVO [J].
CICHUTEK, K ;
MERGET, H ;
NORLEY, S ;
LINDE, R ;
KREUZ, W ;
GAHR, M ;
KURTH, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) :7365-7369
[5]   SPECTRUM OF BIOLOGICAL PROPERTIES OF HUMAN IMMUNODEFICIENCY VIRUS (HIV-1) ISOLATES [J].
CLOYD, MW ;
MOORE, BE .
VIROLOGY, 1990, 174 (01) :103-116
[6]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS WITH INCREASED REPLICATIVE CAPACITY DEVELOP DURING THE ASYMPTOMATIC STAGE BEFORE DISEASE PROGRESSION [J].
CONNOR, RI ;
HO, DD .
JOURNAL OF VIROLOGY, 1994, 68 (07) :4400-4408
[7]   INCREASED VIRAL BURDEN AND CYTOPATHICITY CORRELATE TEMPORALLY WITH CD4+ T-LYMPHOCYTE DECLINE AND CLINICAL PROGRESSION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED INDIVIDUALS [J].
CONNOR, RI ;
MOHRI, H ;
CAO, YZ ;
HO, DD .
JOURNAL OF VIROLOGY, 1993, 67 (04) :1772-1777
[8]   BIOLOGICAL CLONING OF FUNCTIONALLY DIVERSE QUASI-SPECIES OF HIV-1 [J].
CONNOR, RI ;
NOTERMANS, DW ;
MOHRI, H ;
CAO, YZ ;
HO, DD .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (06) :541-546
[9]   HIGH-CONCENTRATIONS OF RECOMBINANT SOLUBLE CD4 ARE REQUIRED TO NEUTRALIZE PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES [J].
DAAR, ES ;
LI, XL ;
MOUDGIL, T ;
HO, DD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) :6574-6578
[10]   TRANSIENT HIGH-LEVELS OF VIREMIA IN PATIENTS WITH PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
DAAR, ES ;
MOUDGIL, T ;
MEYER, RD ;
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :961-964